Norikazu Yabuta Selected Research

Norikazu Yabuta Research Topics

Disease

12	Neoplasms (Cancer) 02/2019 - 03/2006
4	Carcinogenesis 11/2015 - 03/2006
2	Mouth Neoplasms (Oral Cancer) 01/2022 - 02/2019
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2019 - 12/2017
2	Vasculitis (Vasculitides) 01/2019 - 08/2008
2	Carcinoma (Carcinomatosis) 09/2018 - 12/2012
2	Osteosarcoma (Osteogenic Sarcoma) 10/2017 - 01/2014
2	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 01/2014
2	Hypertrophy 02/2013 - 11/2008
2	Warts (Wart) 11/2008 - 05/2004
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2007 - 03/2006
1	Infertility (Sterility) 04/2024
1	Squamous Cell Carcinoma of Head and Neck 02/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2015
1	Adenocarcinoma 01/2015
1	Necrosis 01/2015
1	Chromosomal Instability (Chromosome Stability) 01/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 08/2008
1	Neoplasm Metastasis (Metastasis) 07/2007
1	Melanoma (Melanoma, Malignant) 07/2007
1	Polyploidy 10/2006
1	Epilepsy (Aura) 08/2006
1	Vascular Remodeling 02/2006

Drug/Important Bio-Agent (IBA)

9	Phosphotransferases (Kinase)IBA 01/2022 - 05/2004
3	Messenger RNA (mRNA)IBA 01/2019 - 08/2006
3	Proteins (Proteins, Gene)FDA Link 09/2018 - 11/2010
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2011 - 05/2004
2	Long-Acting Thyroid Stimulator (LATS)IBA 01/2022 - 05/2004
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019 - 12/2017
2	Complementary DNA (cDNA)IBA 09/2018 - 08/2008
2	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 08/2008
2	Gefitinib (Iressa)FDA Link 01/2014 - 01/2011
2	MicroRNAs (MicroRNA)IBA 01/2007 - 03/2006
1	Male Contraceptive Agents (Male Contraceptives)IBA 04/2024
1	Contraceptive Agents (Contraceptives)IBA 04/2024
1	LectinsIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	AcyltransferasesIBA 09/2018
1	Hedgehog ProteinsIBA 09/2018
1	FicolinsIBA 12/2017
1	Immunoglobulins (Immunoglobulin)IBA 12/2017
1	Peptides (Polypeptides)IBA 10/2017
1	Amino Acids FDA Link 10/2017
1	Indicators and Reagents (Reagents)IBA 11/2015
1	Cyclin G2IBA 11/2015
1	withaferin AIBA 01/2015
1	AndrogensIBA 01/2015
1	Cyclin GIBA 01/2014
1	ClathrinIBA 01/2014
1	LuteolinIBA 01/2014
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 02/2013
1	Tamoxifen FDA LinkGeneric 12/2012
1	ErbB Receptors (EGF Receptor)IBA 01/2011
1	Oncogene Proteins (Oncogene Protein)IBA 11/2010
1	Anti-Idiotypic AntibodiesIBA 08/2008
1	Genetic Markers (Genetic Marker)IBA 08/2008
1	oleylamide (oleamide)IBA 07/2007
1	Connexin 26IBA 07/2007
1	NocodazoleIBA 10/2006
1	Chemokine ReceptorsIBA 08/2006
1	NF-kappa B (NF-kB)IBA 08/2006
1	Tacrolimus Binding Proteins (FKBP)IBA 08/2006
1	C-Type Lectins (C-Type Lectin)IBA 08/2006
1	protein-tyrosine sulfotransferase (tyrosylprotein sulfotransferase)IBA 08/2006
1	Lysosomal Membrane ProteinsIBA 02/2006

Therapy/Procedure

3	Therapeutics 02/2019 - 11/2015
1	Subcutaneous Injections 01/2013
1	Intraperitoneal Injections 07/2007